You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

SUMATRIPTAN SUCCINATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sumatriptan Succinate patents expire, and what generic alternatives are available?

Sumatriptan Succinate is a drug marketed by Antares Pharma Inc, Baxter Hlthcare Corp, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hikma, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sandoz, Somerset, Steriscience, Sun Pharm, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Zydus, Aurobindo Pharma, Corepharma, Dr Reddys Labs Inc, Fosun Pharma, Hikma Pharms, Mylan, Orbion Pharms, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in thirty-four NDAs.

The generic ingredient in SUMATRIPTAN SUCCINATE is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sumatriptan Succinate

A generic version of SUMATRIPTAN SUCCINATE was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.

  Try a Trial

Drug patent expirations by year for SUMATRIPTAN SUCCINATE
Drug Prices for SUMATRIPTAN SUCCINATE

See drug prices for SUMATRIPTAN SUCCINATE

Drug Sales Revenue Trends for SUMATRIPTAN SUCCINATE

See drug sales revenues for SUMATRIPTAN SUCCINATE

Recent Clinical Trials for SUMATRIPTAN SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jiangsu Provincial People's HospitalPhase 3
West China HospitalPhase 3
The Second Affiliated Hospital of Kunming Medical UniversityPhase 3

See all SUMATRIPTAN SUCCINATE clinical trials

Pharmacology for SUMATRIPTAN SUCCINATE
Anatomical Therapeutic Chemical (ATC) Classes for SUMATRIPTAN SUCCINATE

US Patents and Regulatory Information for SUMATRIPTAN SUCCINATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 077744-001 Aug 10, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Dr Reddys Labs Inc SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 076847-002 Aug 10, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Roxane SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078241-001 Aug 10, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 076840-003 Feb 9, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 077744-003 Aug 10, 2009 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Roxane SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078241-002 Aug 10, 2009 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.